Greengrade is a subsidiary of Submittal Exchange, a collaborative, secure online system for exchanging, reviewing, and archiving construction submittals, RFIs, and other construction communications electronically.
Individuals most impacted by the rising cost of insulin are the uninsured and the under-insured. These patients are forced to pay the ever-increasing retail sale price (which is increasing due to a variety of factors, including increased wholesale price) or a percentage of this price when buying insulin.
As the older versions have vanished in the U.S., newer versions have stayed expensive. The drug can cost up to $400 a month. Because of that high cost, many of the estimated 29 million people living with diabetes in the U.S. can't afford it. Some industry analysts expect insulin costs to fall in the future.